Associated Papers
Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
Lee SY et al.
Bmc Cancer, 2020
32718341 (PubMed )
Supplement: 12885_2020_7161_MOESM1_ESM.xlsx › Sheet1
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.
Cai W et al.
Bmc Genomics, 2018
30075702 (PubMed )
Supplement: 12864_2018_4958_MOESM5_ESM.xlsx › Supplementary_Figure_4
Select a paper to view details